Palvella Therapeutics, Inc.

PVLA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$140.78+1.25%

2026-08-03

Financials

Valuation Metrics

Palvella Therapeutics, Inc.'s Market Cap is $2.02B. At end of 2025 it was $1.18B. Ranked #2050 of 3,112 in US market (top 66%), #785 of 1,445 on NASDAQ (top 54%), #134 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 50%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.02B	US#2,050/3,112 Sec#134/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-49M	US—/3,112 Sec—/269
Total Assets	$264M	US#2,932/3,112 Sec#229/269
Net Assets	$232M	US#2,677/3,112 Sec#183/269
Value
P/B	8.69x	US#2,542/3,112 Sec#198/269
FCF Yield	-1.44%	US—/3,112 Sec—/269
Profitability
ROE	-21.22%	US#2,537/3,112 Sec#104/269
ROA	-18.69%	US#2,762/3,112 Sec#120/269
Financial Health
Debt Ratio	13.54%	US#154/3,112 Sec#65/269
Total Debt	$584000.00	US#2,948/3,112 Sec#256/269
FCF	$-29M	US#2,405/3,112 Sec#100/269
Cash	$206M	US#1,701/3,112 Sec#112/269
Current Ratio	28.88x	US#85/3,112 Sec#12/269
Performance
1Y Return	285.17%	US#56/3,112 Sec#20/269
1M Return	-4.07%	US#2,147/3,112 Sec#118/269
From 52W High	-12.76%	US#1,251/3,112 Sec#70/269
1Y MDD	-31.11%	US#1,465/3,112 Sec#91/269
Trading
Volume	144,157 shares	US#2,812/3,112 Sec#259/269
Trading Value	$20M	US#1,956/3,112 Sec#146/269
Per Share
EPS	$-3.71	US—/3,112 Sec—/269
BPS	$2.49	US#2,463/3,112 Sec#166/269